Neil Desai, EXECUTIVE CHAIRMAN at Aadi Bioscience, Inc. (AADI), sold 40,000 shares at $1.77 ($72K) on 2024-06-04, disclosed to the SEC on 2024-06-05.
Scheduled sale ($72k) by EXECUTIVE CHAIRMAN under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.81 | 19,775 | $36K | 50.0% |
| 2 | $1.77 | 20,225 | $36K | 50.0% |
| Total | $1.79 avg | 40,000 | $72K | 100% |
| Filing → |
| AADI | SELL | 2024-07-02 | $57K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |
| AADI | SELL | 2024-04-03 | $91K | — | Filing → |